In vivo evolution of biopsy-proven inflammatory demyelination quantified by R2t* mapping

Authors

Biao Xiang, Washington University School of Medicine in St. Louis
Jie Wen, Washington University School of Medicine in St. Louis
Hsiang-Chih Lu, Washington University School of Medicine in St. Louis
Robert E Schmidt, Washington University School of Medicine in St. Louis
Dmitriy A Yablonskiy, Washington University School of Medicine in St. Louis
Anne H Cross, Washington University School of Medicine in St. Louis

Journal

Annals of Clinical and Translational Neurology

Publication Date

6-1-2020

Volume

7

Issue

6

First Page

1055

Last Page

1060

Document Type

Open Access Publication

DOI

10.1002/acn3.51052

Rights and Permissions

Xiang, B., Wen, J., Lu, H.‐C., Schmidt, R.E., Yablonskiy, D.A. and Cross, A.H. (2020), In vivo evolution of biopsy‐proven inflammatory demyelination quantified by R2t* mapping. Ann Clin Transl Neurol, 7: 1055-1060. https://doi.org/10.1002/acn3.51052 © 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

Recommended Citation

Xiang, Biao; Wen, Jie; Lu, Hsiang-Chih; Schmidt, Robert E; Yablonskiy, Dmitriy A; and Cross, Anne H, "In vivo evolution of biopsy-proven inflammatory demyelination quantified by R2t* mapping." Annals of Clinical and Translational Neurology. 7, 6. 1055 - 1060. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9886